Literature DB >> 12221327

Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus.

Melvin R Hayden1.   

Abstract

The presence of amyloid within the islet of the pancreas may be one of the best kept secrets in clinical medicine and translation of this century old finding may help to better understand the progressive nature of type 2 diabetes mellitus. Insulin resistance, metabolic syndrome, and type 2 diabetes mellitus are associated with multiple metabolic toxicities which result in an elevated tension of redox stress within the islet. Redox stress is associated with damage to proteins, lipids, and nucleic acids which may have a profound affect upon the structure and function of the islet. Earlier diagnosis at the stage of impaired glucose tolerance (prediabetes) and intervention may have a positive outcome on stabilization of the vulnerable islet and beta cell as well as the multiple diabetic complications. The natural history and a shift in the treatment paradigm of type 2 diabetes mellitus is explored as a result of these century old findings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221327

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  11 in total

Review 1.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

2.  Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Ghulam M Ashraf; Nigel H Greig; Taqi A Khan; Iftekhar Hassan; Shams Tabrez; Shazi Shakil; Ishfaq A Sheikh; Syed K Zaidi; Mohammad Akram; Nasimudeen R Jabir; Chelaprom K Firoz; Aabgeena Naeem; Ibrahim M Alhazza; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

Review 3.  A reappraisal of the blood glucose homeostat which comprehensively explains the type 2 diabetes mellitus-syndrome X complex.

Authors:  Johan H Koeslag; Peter T Saunders; Elmarie Terblanche
Journal:  J Physiol       Date:  2003-04-25       Impact factor: 5.182

4.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

5.  Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.

Authors:  Tatsuo Tomita
Journal:  Islets       Date:  2012 May-Jun       Impact factor: 2.694

6.  Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide.

Authors:  Jessica A Williamson; J Patrick Loria; Andrew D Miranker
Journal:  J Mol Biol       Date:  2009-07-30       Impact factor: 5.469

7.  Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression.

Authors:  Huarong Zhou; Shigeru Saito; Guanying Piao; Zhi-Ping Liu; Jiguang Wang; Katsuhisa Horimoto; Luonan Chen
Journal:  BMC Syst Biol       Date:  2011-06-20

8.  An autosome-wide search using longitudinal data for loci linked to type 2 diabetes progression.

Authors:  Gyungah Jun; Yeunjoo Song; Catherine M Stein; Sudha K Iyengar
Journal:  BMC Genet       Date:  2003-12-31       Impact factor: 2.797

9.  Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Cardiovasc Diabetol       Date:  2003-02-12       Impact factor: 9.951

10.  Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Cardiovasc Diabetol       Date:  2002-09-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.